Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Vanguard Value ETF
VTV
$145B
| $1.8M | ﹤0.01% |
10,200
-12,000
| -54% | -$2.12M |
|
2177
Mid Penn Bancorp
MPB
$691M
| $1.8M | ﹤0.01% |
63,898
+13,340
| +26% | +$376K |
|
2178
BayCom
BCML
$324M
| $1.79M | ﹤0.01% |
64,600
-6,600
| -9% | -$183K |
|
2179
Lineage Cell Therapeutics
LCTX
$306M
| $1.79M | ﹤0.01% |
1,972,335
-319,046
| -14% | -$290K |
|
2180
Hingham Institution for Saving
HIFS
$625M
| $1.79M | ﹤0.01% |
7,189
-800
| -10% | -$199K |
|
2181
Apogee Therapeutics
APGE
$2.2B
| $1.78M | ﹤0.01% |
+41,100
| New | +$1.78M |
|
2182
LCNB Corp
LCNB
$223M
| $1.78M | ﹤0.01% |
122,816
-2,800
| -2% | -$40.7K |
|
2183
Vanguard S&P 500 Growth ETF
VOOG
$19.9B
| $1.78M | ﹤0.01% |
+4,500
| New | +$1.78M |
|
2184
Lindblad Expeditions
LIND
$735M
| $1.78M | ﹤0.01% |
152,799
-28,500
| -16% | -$333K |
|
2185
First Savings Financial Group
FSFG
$189M
| $1.78M | ﹤0.01% |
71,052
+19,352
| +37% | +$485K |
|
|
MTLS
2186
Materialise
MTLS
$302M
| $1.78M | ﹤0.01% |
314,300
+200
| +0.1% | +$1.13K |
|
2187
Zentalis Pharmaceuticals
ZNTL
$107M
| $1.77M | ﹤0.01% |
1,529,553
+703,512
| +85% | +$816K |
|
2188
Oceaneering
OII
$2.43B
| $1.77M | ﹤0.01% |
85,600
+31,500
| +58% | +$653K |
|
2189
Coffee Holding Co
JVA
$24.4M
| $1.77M | ﹤0.01% |
409,592
-19,072
| -4% | -$82.6K |
|
2190
Virco
VIRC
$126M
| $1.77M | ﹤0.01% |
222,111
+2,100
| +1% | +$16.8K |
|
2191
AmeriServ Financial
ASRV
$47.4M
| $1.77M | ﹤0.01% |
582,776
+12,602
| +2% | +$38.3K |
|
2192
Global X Silver Miners ETF NEW
SIL
$3.19B
| $1.77M | ﹤0.01% |
+36,700
| New | +$1.77M |
|
2193
Jamf
JAMF
$1.41B
| $1.76M | ﹤0.01% |
185,400
+42,465
| +30% | +$404K |
|
2194
Valero Energy
VLO
$48.7B
| $1.76M | ﹤0.01% |
13,100
-104,900
| -89% | -$14.1M |
|
2195
WisdomTree Japan Hedged Equity Fund
DXJ
$3.82B
| $1.76M | ﹤0.01% |
15,400
-1,700
| -10% | -$194K |
|
|
MFA
2196
MFA Financial
MFA
$1.04B
| $1.76M | ﹤0.01% |
185,950
-153,875
| -45% | -$1.46M |
|
2197
Alector
ALEC
$278M
| $1.76M | ﹤0.01% |
1,254,850
+220,995
| +21% | +$309K |
|
2198
Journey Medical
DERM
$187M
| $1.75M | ﹤0.01% |
243,500
+5,500
| +2% | +$39.5K |
|
|
SY
2199
So-Young International
SY
$374M
| $1.75M | ﹤0.01% |
563,228
-18,000
| -3% | -$55.8K |
|
2200
Ingevity
NGVT
$2.12B
| $1.74M | ﹤0.01% |
40,400
+7,300
| +22% | +$315K |
|